Blank Bio Raises $7.2M Seed

Blank Bio, based in San Francisco, is an artificial intelligence startup focused on developing RNA foundation models for precision medicine. The company has raised $7.2 million in seed financing to advance its computational models and expand its research partnerships.

Investors

Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire, and Y Combinator.

Blank Bio Use of Funds

Blank Bio plans to use the capital to double down on model development, generate additional training data, and expand collaborations with pharmaceutical and diagnostic companies.

About Blank Bio

Founded in 2025 by Jonathan Hsu, Philip Fradkin, and Ian Shi, Blank Bio is an AI technology company dedicated to creating RNA foundation models. The company aims to leverage bulk RNA sequencing data to provide clinical insights for oncology and other disease indications, with a goal of enabling end-to-end transcriptomic analysis for pharmaceutical and diagnostic applications.

Funding Details

Company: Blank Bio
Raised: $7.2M
Round: Seed
Funding Date: May 19, 2026
Additional Investors: Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire, Y Combinator
Software Category: Healthcare AI
Company Website: https://blank.bio
Source: https://www.genomeweb.com/informatics/blank-bio-raises-72m-seed-funding-rna-foundation-model-development